Selective HDAC4 inhibition by SP1-PTD promotes odontoblast differentiation

Area of Science:

• Biomaterials and Regenerative Medicine
• Molecular Biology and Pharmacology

Background:

• Vital pulp therapy faces challenges in dentin regeneration and toxicity from current histone deacetylase (HDAC) inhibitors.
• Structural studies identified key interactions between HDAC4 and SMRT, enabling targeted inhibition strategies.

Purpose of the Study:

• To evaluate SMRT peptide 1-protein transduction domain (SP1-PTD) for promoting odontoblast differentiation and dentin regeneration.
• To assess SP1-PTD's safety profile compared to pan-HDAC inhibitors in dental applications.

Main Methods:

• SP1-PTD, a cell-penetrating peptide, was designed to selectively disrupt HDAC4-SMRT interaction.
• Effects on odontoblast differentiation were studied in cell lines and primary cells using gene expression, mineralization assays, and mechanistic analyses.
• Cytotoxicity was compared with suberoylanilide hydroxamic acid (SAHA) and trichostatin A.

Main Results:

• SP1-PTD significantly enhanced odontoblast differentiation, increasing dentin sialophosphoprotein (Dspp) expression by 15.9-fold and mineralization capacity by 1.8-fold.
• Mechanistically, SP1-PTD increased RUNX2 acetylation and histone acetylation at the Dspp promoter.
• SP1-PTD demonstrated no cytotoxicity and promoted cell proliferation, unlike the dose-dependent toxicity of SAHA, which suppressed Dspp expression.

Conclusions:

• SP1-PTD is a first-in-class selective HDAC4 inhibitor with robust pro-differentiation effects and an excellent safety profile.
• Targeting HDAC4-SMRT interactions with SP1-PTD overcomes limitations of conventional HDAC inhibitors.
• SP1-PTD shows significant promise for dental regenerative medicine.